MoneyWorks4Me

Dr Reddys Laboratories informs about press release

21 Mar 2026 Evaluate
Dr Reddys Laboratories has informed that it enclosed a Press Release ‘Dr. Reddy’s Laboratories announces launch of India’s first DCGI-approved Semaglutide injection ‘Obeda’ for Type 2 Diabetes’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1790.95
Dr. Reddys Labs. 1201.20
Cipla 1324.75
Lupin 1999.45
Zydus Lifesciences 1134.00
View more..